Physicians' Academy for Cardiovascular Education
What are the future directions in development?

What are the future directions in development?

Podcast - Nov. 1, 2020 - Prof. John E Deanfield, MD

Prof. Deanfield discusses the changing paradigm for managing cardiometabolic risk in clinical practice by the emergence of diabetes. He states that GLP-1 receptor agonists will be an important component of treatment strategies.

Listen to the podcast: